Capstone Investment Advisors, LLC Pacific Biosciences Of California, Inc. Transaction History

Capstone Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$3.52 - $9.59 $151,180 - $411,880	42,949 Added 227.95%	61,790 $231,000
Q4 2023 Feb 12, 2024	BUY	$5.97 - $10.36 $112,480 - $195,192	18,841 New	18,841 $184,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $42,201 - $109,494	-10,498 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.43 - $20.9 $88,498 - $219,408	10,498 New	10,498 $96,000
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $484,595 - $1.08 Million	-205,337 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $69,496 - $84,151	-15,108 Reduced 6.85%	205,337 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $1.16 Million - $1.43 Million	-231,785 Reduced 51.25%	220,445 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $1.21 Million - $1.52 Million	204,917 Added 82.86%	452,230 $2.74 Million
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $2.52 Million - $2.74 Million	-370,579 Reduced 59.97%	247,313 $1.79 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $2.47 Million - $4.83 Million	617,892 New	617,892 $4.57 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.